Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Amgen (NASDAQ:AMGN).
Industry description
The investment seeks to provide capital appreciation.
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Health Care Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Health Care Companies that have small to mid-sized capitalizations. The fund also may purchase American Depositary Receipts ("ADRs") to gain exposure to foreign Health Care Companies and U.S. government securities.
Market Cap
The average market capitalization across the Rydex Health Care Inv MF is 330.95B. The market cap for tickers in the group ranges from 154.97B to 910.93B. LLY holds the highest valuation in this group at 910.93B. The lowest valued company is DHR at 154.97B.
Volume
The average weekly volume growth across all stocks in the Rydex Health Care Inv MF was 14%. For the same stocks of the MF, the average monthly volume growth was 60% and the average quarterly volume growth was -49%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 46
P/E Growth Rating: 67
Price Growth Rating: 32
SMR Rating: 35
Profit Risk Rating: 46
Seasonality Score: 24 (-100 ... +100)